Litigation Or Legislation: States Have Dual Path For Pharma Regulation
Executive Summary
States make decisions about whether to use legislation or litigation to address questionable behavior by pharmaceutical companies based on the required scope and speed of the remedial activity, Vermont Assistant Attorney General Julie Brill said